Ryan P - Search Results

1

Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study.

Yuan Z, DeFalco F, Wang L, Hester L, Weaver J, Swerdel JN, Freedman A, Ryan P, Schuemie M, Qiu R, Yee J, Meininger G, Berlin JA, Rosenthal N. Yuan Z, et al. Among authors: ryan p. Curr Med Res Opin. 2020 Jul;36(7):1117-1124. doi: 10.1080/03007995.2020.1761312. Epub 2020 May 14. Curr Med Res Opin. 2020. PMID: 32338068

2

Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure.

Defalco FJ, Ryan PB, Soledad Cepeda M. Defalco FJ, et al. Health Serv Outcomes Res Methodol. 2013 Mar;13(1):58-67. doi: 10.1007/s10742-012-0102-1. Epub 2012 Oct 27. Health Serv Outcomes Res Methodol. 2013. PMID: 23396660 Free PMC article.

3

Evaluating the impact of database heterogeneity on observational study results.

Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, Suchard MA, DuMouchel W, Berlin JA. Madigan D, et al. Am J Epidemiol. 2013 Aug 15;178(4):645-51. doi: 10.1093/aje/kwt010. Epub 2013 May 5. Am J Epidemiol. 2013. PMID: 23648805 Free PMC article.

4

Interpreting observational studies: why empirical calibration is needed to correct p-values.

Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Schuemie MJ, et al. Stat Med. 2014 Jan 30;33(2):209-18. doi: 10.1002/sim.5925. Epub 2013 Jul 30. Stat Med. 2014. PMID: 23900808 Free PMC article.

5

Discussion: An estimate of the science-wise false discovery rate and application to the top medical literature.

Schuemie MJ, Ryan PB, Suchard MA, Shahn Z, Madigan D. Schuemie MJ, et al. Biostatistics. 2014 Jan;15(1):36-9; discussion 39-45. doi: 10.1093/biostatistics/kxt037. Epub 2013 Sep 25. Biostatistics. 2014. PMID: 24068252 Free PMC article. No abstract available.

6

Multiple self-controlled case series for large-scale longitudinal observational databases.

Simpson SE, Madigan D, Zorych I, Schuemie MJ, Ryan PB, Suchard MA. Simpson SE, et al. Biometrics. 2013 Dec;69(4):893-902. doi: 10.1111/biom.12078. Epub 2013 Oct 11. Biometrics. 2013. PMID: 24117144

7

Desideratum for evidence based epidemiology.

Overhage JM, Ryan PB, Schuemie MJ, Stang PE. Overhage JM, et al. Drug Saf. 2013 Oct;36 Suppl 1:S5-14. doi: 10.1007/s40264-013-0102-2. Drug Saf. 2013. PMID: 24166219 Review.

8

Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey.

Stang PE, Ryan PB, Overhage JM, Schuemie MJ, Hartzema AG, Welebob E. Stang PE, et al. Drug Saf. 2013 Oct;36 Suppl 1:S15-25. doi: 10.1007/s40264-013-0103-1. Drug Saf. 2013. PMID: 24166220

9

Defining a reference set to support methodological research in drug safety.

Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Ryan PB, et al. Drug Saf. 2013 Oct;36 Suppl 1:S33-47. doi: 10.1007/s40264-013-0097-8. Drug Saf. 2013. PMID: 24166222 Review.

10

Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system.

Ryan PB, Schuemie MJ, Gruber S, Zorych I, Madigan D. Ryan PB, et al. Drug Saf. 2013 Oct;36 Suppl 1:S59-72. doi: 10.1007/s40264-013-0099-6. Drug Saf. 2013. PMID: 24166224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,553 results

Search Page

Filters